209 related articles for article (PubMed ID: 31888613)
1. Economic burden of Huntington's disease in Peru.
Silva-Paredes G; Urbanos-Garrido RM; Inca-Martinez M; Rabinowitz D; Cornejo-Olivas MR
BMC Health Serv Res; 2019 Dec; 19(1):1017. PubMed ID: 31888613
[TBL] [Abstract][Full Text] [Related]
2. Economic burden of Huntington disease in Europe and the USA: Results from the Huntington's Disease Burden of Illness study.
Rodríguez-Santana I; Mestre T; Squitieri F; Willock R; Arnesen A; Clarke A; D'Alessio B; Fisher A; Fuller R; Hamilton JL; Hubberstey H; Stanley C; Vetter L; Winkelmann M; Doherty M; Wu Y; Finnegan A; Frank S
Eur J Neurol; 2023 Apr; 30(4):1109-1117. PubMed ID: 36421029
[TBL] [Abstract][Full Text] [Related]
3. Economic Burden of Huntington's Disease in China: Results from a National-Wide Cross-Sectional Study.
Chen S; Zhang H; Yu J; Cao X; Zhang S; Dong D
Neuroepidemiology; 2024; 58(1):31-36. PubMed ID: 38142687
[TBL] [Abstract][Full Text] [Related]
4. The societal cost of Huntington's disease: are we underestimating the burden?
Jones C; Busse M; Quinn L; Dawes H; Drew C; Kelson M; Hood K; Rosser A; Edwards RT
Eur J Neurol; 2016 Oct; 23(10):1588-90. PubMed ID: 27461550
[TBL] [Abstract][Full Text] [Related]
5. The direct medical costs of Huntington's disease by stage. A retrospective commercial and Medicaid claims data analysis.
Divino V; Dekoven M; Warner JH; Giuliano J; Anderson KE; Langbehn D; Lee WC
J Med Econ; 2013 Aug; 16(8):1043-50. PubMed ID: 23789925
[TBL] [Abstract][Full Text] [Related]
6. Economic burden of schizophrenia: empirical analyses from a survey in Thailand.
Phanthunane P; Whiteford H; Vos T; Bertram M
J Ment Health Policy Econ; 2012 Mar; 15(1):25-32. PubMed ID: 22611090
[TBL] [Abstract][Full Text] [Related]
7. Healthcare utilization and direct medical costs of Huntington's disease among Medicaid beneficiaries in the United States.
Patel AM; Chang E; Paydar C; Reddy SR
J Med Econ; 2023; 26(1):811-820. PubMed ID: 37285853
[TBL] [Abstract][Full Text] [Related]
8. Health related quality of life, service utilization and costs for patients with Huntington's disease in Norway.
van Walsem MR; Frich JC; Gómez Castañeda M; Howe EI; Pihlstrøm L; Andelic N; Aas E
BMC Health Serv Res; 2022 Dec; 22(1):1527. PubMed ID: 36517848
[TBL] [Abstract][Full Text] [Related]
9. Economic burden of specific learning disability: A prevalence-based cost of illness study of its direct, indirect, and intangible costs.
Karande S; D'souza S; Gogtay N; Shiledar M; Sholapurwala R
J Postgrad Med; 2019; 65(3):152-159. PubMed ID: 31169134
[TBL] [Abstract][Full Text] [Related]
10. Economic Burden of Mental Illnesses in Pakistan.
Malik MA; Khan MM
J Ment Health Policy Econ; 2016 Sep; 19(3):155-66. PubMed ID: 27572143
[TBL] [Abstract][Full Text] [Related]
11. Economic burden of slow learners: A prevalence-based cost of illness study of its direct, indirect, and intangible costs.
Karande S; Ramadoss D; Gogtay N
J Postgrad Med; 2019; 65(4):219-226. PubMed ID: 31441438
[TBL] [Abstract][Full Text] [Related]
12. Survey of the Huntington's Disease Patient and Caregiver Community Reveals Most Impactful Symptoms and Treatment Needs.
Simpson JA; Lovecky D; Kogan J; Vetter LA; Yohrling GJ
J Huntingtons Dis; 2016 Dec; 5(4):395-403. PubMed ID: 27983566
[TBL] [Abstract][Full Text] [Related]
13. Scenarios to manage the hepatitis C disease burden and associated economic impact of treatment in Turkey.
Örmeci N; Malhan S; Balık İ; Ergör G; Razavi H; Robbins S
Hepatol Int; 2017 Nov; 11(6):509-516. PubMed ID: 29027109
[TBL] [Abstract][Full Text] [Related]
14. [Financial burden of hepatitis B-related diseases and factors influencing the costs in Shenzhen, China].
Liang S; Zhang SX; Ma QS; Xiao HW; Lü QY; Xie X; Mei SJ; Hu DS; Zhou BP; Li B; Chen JF; Cui FQ; Wang FZ; Liang XF
Zhonghua Liu Xing Bing Xue Za Zhi; 2010 Dec; 31(12):1340-5. PubMed ID: 21223660
[TBL] [Abstract][Full Text] [Related]
15. The Economic Burden of Asthma in Greece: A Cross-Sectional Study.
Vellopoulou K; Bakakos P; Loukides S; Maniadakis N; Kourlaba G
Appl Health Econ Health Policy; 2019 Oct; 17(5):629-640. PubMed ID: 30997609
[TBL] [Abstract][Full Text] [Related]
16. The societal burden of blindness secondary to retinopathy of prematurity in Lima, Peru.
Dave HB; Gordillo L; Yang Z; Zhang MS; Hubbard GB; Olsen TW
Am J Ophthalmol; 2012 Oct; 154(4):750-5. PubMed ID: 22831839
[TBL] [Abstract][Full Text] [Related]
17. Informal care in Huntington's disease: Assessment of objective-subjective burden and its associated risk and protective factors.
Bayen E; de Langavant LC; Youssov K; Bachoud-Lévi AC
Ann Phys Rehabil Med; 2023 May; 66(4):101703. PubMed ID: 36055643
[TBL] [Abstract][Full Text] [Related]
18. Economic burden of major depressive disorder: a case study in Southern Iran.
Keshavarz K; Hedayati A; Rezaei M; Goudarzi Z; Moghimi E; Rezaee M; Lotfi F
BMC Psychiatry; 2022 Aug; 22(1):577. PubMed ID: 36042423
[TBL] [Abstract][Full Text] [Related]
19. Social/economic costs and health-related quality of life in patients with epidermolysis bullosa in Europe.
Angelis A; Kanavos P; López-Bastida J; Linertová R; Oliva-Moreno J; Serrano-Aguilar P; Posada-de-la-Paz M; Taruscio D; Schieppati A; Iskrov G; Brodszky V; von der Schulenburg JM; Chevreul K; Persson U; Fattore G;
Eur J Health Econ; 2016 Apr; 17 Suppl 1(Suppl 1):31-42. PubMed ID: 27107597
[TBL] [Abstract][Full Text] [Related]
20. Economic burden of type-2 diabetes in Peru: a cost-of-illness study valuing cost differences associated with the level of glycemic control.
Seinfeld J; Sobrevilla A; Rosales ML; Ibáñez M; Ruiz D; Penny E; Londoño S
Expert Rev Pharmacoecon Outcomes Res; 2024 Jun; 24(5):661-669. PubMed ID: 38584495
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
